Multidisciplinary cancer care in Delhi

Cancer treatment in Delhi

Delhi offers pathology, radiology, surgical oncology, radiation oncology, medical and hematologic oncology, intensive care, rehabilitation, and supportive care across institutional and private systems. A safe comparison begins with the exact cancer type, stage, biomarkers, current symptoms, and goal of care; only then can a treatment sequence and realistic budget be built.

How much can cancer treatment in Delhi cost?

A 2026 private-care pathway may range from about INR 5,00,000 for selected localized treatment to INR 75,00,000+ (USD 5,200 to 77,800+) for prolonged multimodal, targeted, cellular, intensive, or complication-heavy care. “Cancer treatment” is not one package: pathology, stage, surgery, radiation fractions, drug name and dose, number of cycles, response, toxicity, and duration drive the total.

USD illustrations use the RBI reference of INR 96.3665 per USD displayed for 17 July 2026. Reprice the pathway after pathology, staging, tumor-board review, and each major response assessment.

Review city costs Upload reports

Let Us Help You

Share the basics and the Virello team will guide you toward the next step.

Prefer email? Write to support@virellohealth.com.

Patient Name

Country

Phone Number

Describe The Current Medical Problem

Reviewed 2026-07-20

Clinical review: Virello Health Medical Review Team · Editorial review: Virello Health Editorial Team

Planning currency: INR and USD

First decision

Confirm tissue diagnosis, subtype, stage, biomarkers, fitness, symptoms, and treatment intent before comparing hospitals or costs.

Possible modalities

Surgery, radiation, chemotherapy, endocrine, targeted, immune, transplant, cellular, interventional, supportive, or palliative care may be used alone or in sequence.

Delhi stay

A diagnostic visit may take days; surgery may require weeks; radiation or systemic therapy can require repeated visits over months.

Core team

Organ-specific oncologists, radiologist, pathologist, surgeon, radiation and medical oncologists, nurses, pharmacists, nutrition, rehabilitation, and supportive care.

Budget unit

Compare complete courses and response checkpoints, not a single operation, radiation fraction, infusion, or headline package.

Why this city

How Delhi may fit this treatment pathway

Delhi can support complex multidisciplinary cancer planning and several independent opinions. AIIMS officially documents surgical oncology and radiation oncology services, illustrating the need for connected specialties; patients should verify the exact campus because some services and the National Cancer Institute are geographically separate from central Delhi.

Multidisciplinary depth

Organ-focused surgery, medical oncology, radiation, imaging, pathology, intensive care, pain, nutrition, and rehabilitation can be coordinated within major systems.

Pathology and molecular access

Tissue review, immunohistochemistry, cytogenetics, and selected molecular tests can refine diagnosis and drug eligibility before expensive treatment begins.

Institutional and private options

Public and private pathways differ in access time, cost, rooms, and scheduling. Urgency and diagnosis-specific expertise should guide choice.

Follow-up network

Laboratories, imaging, pharmacies, transfusion support, emergency departments, and palliative services can support treatment between major interventions.

Candidate context

Who may be assessed for cancer treatment

Treatment suitability depends on cancer origin and subtype, anatomic and molecular stage, symptoms, previous therapy, organ function, performance, fertility goals, nutrition, infection, and personal priorities. Some patients need urgent symptom control before full staging; others benefit from pathology review or observation rather than immediate intervention.

Verified diagnosis

Adequate tissue, expert pathology, and relevant biomarkers should support the cancer label and proposed therapy.

Complete stage

Appropriate imaging, examination, laboratory work, marrow or endoscopic assessment when indicated determine whether treatment is local, systemic, or combined.

Treatment intent

Curative, disease-controlling, symptom-relieving, or diagnostic goals change the acceptable burden, duration, risk, and cost.

Patient reserve and wishes

Function, nutrition, kidneys, liver, marrow, heart, lungs, infection, frailty, fertility, quality of life, and informed preferences shape the plan.

Urgency and travel safety

When timing or symptoms change the plan

Possible oncologic emergency

Severe breathlessness, uncontrolled bleeding, new paralysis, confusion, seizures, bowel obstruction, fever during chemotherapy, or rapidly worsening pain needs urgent local care.

Do not wait to fly.

Time-sensitive diagnosis

Acute leukemia, aggressive lymphoma, germ-cell cancer, spinal compression, airway threat, or rapidly progressive disease may require immediate specialist action.

Coordinate transfer only when stable.

Stable new diagnosis

Remote pathology and imaging review can clarify stage, team, tests, sequence, and estimate before travel.

Avoid repeating low-value tests.

Progression after treatment

A second opinion should review prior pathology, exact drugs and doses, radiation plans, operations, response scans, toxicity, and current function.

Later-line options are diagnosis-specific.

Treatment options

The procedure name may cover different plans

Technique, disease extent, devices, medicines, prior treatment, and patient health can change the team, hospital support, stay, recovery, and estimate.

Local treatment

Surgery, external or internal radiation, ablation, embolization, or another organ-directed procedure may treat a primary or limited metastasis.

Margins and normal-organ risk matter.

Systemic treatment

Chemotherapy, endocrine, targeted, immunotherapy, antibody, cellular, or radionuclide therapy may treat disease throughout the body.

Drug, biomarker, dose, and cycle count must be named.

Combined sequence

Treatment may occur before surgery, after surgery, concurrently with radiation, or in maintenance phases.

Price every phase and decision point.

Supportive or palliative pathway

Pain, symptoms, nutrition, transfusions, infection, rehabilitation, and psychosocial support can accompany active treatment or become the main goal.

Supportive care is active care.

City treatment pathway

From report review to follow-up in Delhi

1. Diagnostic file review

Send pathology report and slides or blocks process, imaging in DICOM, symptoms, stage, prior treatment, medicines, and current clinical note.

2. Pathology and stage confirmation

Delhi teams may review tissue, add essential biomarkers, repeat selected imaging, and resolve conflicts before recommending treatment.

3. Multidisciplinary plan

The organ-specific tumor board defines intent, sequence, alternatives, expected benefit, risks, fertility or function considerations, and response checkpoints.

4. Written pathway estimate

Price named surgery, radiation technique and fractions, drug and dose per cycle, tests, supportive medicines, admission assumptions, and likely duration.

5. Treatment and toxicity monitoring

Laboratory, imaging, symptom, organ-function, infection, nutrition, and rehabilitation review guide dose, delays, or changes.

6. Response and continuity

A planned checkpoint determines surveillance, completion, maintenance, another line, rehabilitation, survivorship, or symptom-focused care.

City cost scenarios

Planning ranges for cancer treatment in Delhi

These dated scenarios help compare scope; they are not guaranteed packages. A hospital estimate should replace them after the reports, procedure variant, likely stay, and special requirements are reviewed.

Estimated cancer treatment cost scenarios in Delhi
Scenario	INR	USD	Patient context	Planning scope
Selected localized pathway	INR 5,00,000 - 15,00,000	USD 5,200 - 15,600	Confirmed localized disease treated with one principal surgery or a defined radiation course and routine recovery.	Specified diagnostics, named local treatment, expected admission or fractions, routine pathology and early review; systemic therapy and complications require separate scope.
Multimodal treatment course	INR 15,00,000 - 35,00,000	USD 15,600 - 36,300	Surgery plus radiation and/or several cycles of conventional systemic therapy, additional biomarkers, repeated imaging, and supportive care.	Phase-by-phase allowance with response checkpoints. Drug brands, doses, cycle count, radiation technique, admissions, and supportive medicines must be itemized.
Prolonged advanced or high-complexity care	INR 35,00,000 - 75,00,000+	USD 36,300 - 77,800+	Targeted or immune medicines, complex surgery, transplant or cellular pathway, prolonged treatment, ICU, major toxicity, recurrence, or several treatment lines.	Not a ceiling or prediction. Exact disease, body-size dosing, duration, complications, travel, accommodation, and changing response can move cost materially.

Usually included

Check what the clinical range covers

Diagnostic review

Specified specialist consultations, pathology review, imaging review, and routine baseline tests.

New biopsy and molecular testing may be extra.

Named treatment

The exact operation, radiation course, infusion, or medicine listed in the estimate.

Avoid generic “cancer package” wording.

Routine delivery

Defined operating or treatment facility, clinicians, standard consumables, nursing, and stated admission or visit schedule.

Check after-hours and ICU terms.

Monitoring

Specified blood tests, imaging, consultations, and toxicity checks during the quoted phase.

Response scans may be separate.

Early follow-up

Discharge summary or treatment record, medicine plan, warning signs, and scheduled review.

Long-term surveillance is distinct.

Confirm separately

Costs that may sit outside the range

Unconfirmed diagnosis work

Repeat biopsy, anesthesia, endoscopy, interventional radiology, expert pathology, molecular panels, and external tests may add cost.

Test only when it changes care.

Unlisted medicines

Targeted, immune, growth-factor, anti-infective, antiemetic, pain, blood-product, and take-home drugs may be outside a base quote.

Use generic and brand names.

Treatment changes

Extra cycles, dose escalation, new line, surgery, re-irradiation, emergency admission, or treatment delay can revise the budget.

Build response checkpoints.

Toxicity and complications

Neutropenic fever, bleeding, organ injury, thrombosis, ICU, nutrition support, infection, or reoperation commonly sits outside routine scope.

Ask about emergency rates.

Living and continuity costs

Visa, flights, accommodation, attendant, local transport, rehabilitation, home monitoring, and future surveillance are separate.

Long courses need a monthly living budget.

Estimate variables

What can change the final hospital cost

Compare the assumptions behind each number, not only the top and bottom of the range.

Cancer type and stage

Breast, lung, blood, brain, gastrointestinal, genitourinary, sarcoma, and other cancers use different tests and treatment durations.

A generic estimate is unreliable.

Pathology and biomarkers

Immunohistochemistry, cytogenetics, sequencing, receptor, mutation, and expression tests can alter both eligibility and drug cost.

Ask which result changes treatment.

Treatment sequence

Neoadjuvant, definitive, adjuvant, concurrent, maintenance, salvage, and palliative phases have different resource profiles.

Map every planned phase.

Drug and body-size dosing

Generic versus branded medicine, dose per square meter or weight, schedule, wastage policy, and duration determine systemic cost.

Request per-cycle arithmetic.

Radiation technique

Site, fractions, planning, image guidance, motion control, brachytherapy, stereotactic technique, and re-irradiation alter price.

Compare complete courses.

Response and toxicity

Disease behavior and treatment tolerance may shorten, extend, pause, or replace the original plan.

No fixed quote can remove uncertainty.

Hospital capability

Services the hospital should demonstrate

Diagnosis-specific tumor board

Verify organ-focused surgery, medical and radiation oncology, radiology, pathology, and supportive specialties for the exact cancer.

Pathology governance

The center should track specimens, blocks, slides, stains, molecular tests, turnaround, outside review, and release for future care.

Safe treatment delivery

Check oncology pharmacy, dosing verification, radiation quality assurance, infection control, blood bank, emergency assessment, and ICU backup.

Toxicity and symptom support

Nutrition, pain, palliative care, psycho-oncology, rehabilitation, fertility, stoma, wound, and infection services should match likely needs.

Continuity systems

Treatment summaries, dose records, radiation plans, pathology, images, response criteria, emergency contact, and home-team handover should be exportable.

Shortlist questions

Verify capability before the package price

Exact diagnosis

Is pathology sufficient, which findings remain uncertain, and which additional test will change management?

Do not treat a provisional label as final.

Named tumor board

Which organ specialists reviewed the case, what is the intent, and what alternatives were considered?

Request a written plan.

Complete sequence

List surgery, radiation, drug, cycle, response assessment, maintenance, and surveillance phases.

Avoid one-line packages.

Delivery safety

Verify pharmacy, radiation QA, infection, transfusion, ICU, emergency oncology, and complication pathways.

Confirm the actual campus.

Itemized estimate

Check tests, drug name and dose, cycles, fractions, admission, devices, blood, supportive medicines, and exclusions.

Reprice at decision points.

Home handover

Can the hospital release pathology material, DICOM imaging, operation and radiation records, drug doses, toxicity history, and follow-up plan?

Portability is essential.

Treating team

Specialists and support roles that may matter

Organ-specific oncologist

Leads diagnosis-specific decisions and explains intent, sequence, alternatives, expected benefit, uncertainty, and response criteria.

Pathologist and radiologist

Confirm disease identity and extent, select useful biomarkers, compare serial studies, and preserve portable source material.

Surgical, radiation and medical oncology

Plan local and systemic modalities around one another to avoid unnecessary delay, duplication, or incompatible treatment.

Supportive-care team

Oncology nursing, pharmacy, nutrition, pain and palliative care, rehabilitation, fertility, psychosocial, infection, and coordination protect function and continuity.

City care ecosystem

Support beyond one department

Comprehensive oncology systems

Delhi has institutional and private networks, but organ-specific services, technologies, appointment time, and campus locations must be verified.

Diagnostic depth

Advanced imaging, interventional biopsy, hematopathology, molecular laboratories, and outside-review options can resolve difficult cases.

Acute support

Blood banks, antimicrobial care, emergency oncology, intensive care, surgery, endoscopy, and interventional radiology matter during complications.

Long-course living support

Nearby lodging, safe food, transport, pharmacies, infusion access, rehabilitation, and communication help patients completing repeated visits.

Alternative cities

When another Indian center may fit better

No city is the universal choice. Compare referral depth, timing, travel burden, continuity, and complete cost around the individual case.

Gurgaon

Compare for a specific private oncology program, technology, trial, room timeline, or airport-side stay.

Check campus and emergency route.

Mumbai, Chennai, or Bangalore

Another center may offer stronger expertise for a rare subtype, organ-specific surgery, cellular therapy, or family travel needs.

Compare diagnosis-matched teams.

Shared care near home

Selected infusions, laboratory monitoring, rehabilitation, symptom care, or surveillance may be delivered locally under a documented plan.

Confirm responsibility for emergencies.

Local logistics

Plan arrival, hospital access, and daily support in Delhi

Locate every campus

Consultation, surgery, radiation, infusion, imaging, and the NCI campus may not be in one place; map travel before booking accommodation.

Stay near the active treatment site

Fatigue, nausea, pain, low blood counts, or mobility limits can make repeated cross-city journeys unsafe or exhausting.

Use flexible lodging

Pathology, toxicity, infection, treatment delays, and response results can change dates; avoid rigid checkout and flight commitments.

Protect against infection

Use safe food and water, hand hygiene, mask advice when prescribed, rapid fever access, and clinician-approved visitors during immune suppression.

Plan an informed attendant

The companion should understand medicines, fever thresholds, appointments, nutrition, mobility, documents, and emergency contacts.

Maintain a portable record

Keep pathology, imaging, treatment doses, radiation plan, operations, laboratory trends, allergies, toxicity, and emergency numbers together.

Treatment timeline

Expected checkpoints from planning to return home

Remote triage

Records identify emergencies, missing diagnostic evidence, likely specialties, and whether travel should wait.

Confirmation

Pathology, biomarkers, imaging, stage, baseline organ function, and performance are verified.

Tumor-board plan

The team documents intent, sequence, alternatives, fertility or function issues, milestones, and complete phase estimates.

Treatment phase

Surgery, radiation, systemic therapy, or combined care proceeds with toxicity and supportive monitoring.

Response checkpoint

Examination, imaging, pathology, markers, symptoms, and tolerance determine completion, maintenance, change, or surveillance.

Continuity handover

The home team receives the complete treatment record, risks, medicines, surveillance schedule, rehabilitation, and rapid-recontact plan.

Recovery and continuity

Protect the handover after discharge

Use diagnosis-specific warning signs

Fever during immune suppression, bleeding, breathlessness, new neurologic symptoms, severe dehydration, or uncontrolled pain may require immediate care.

Track toxicity and function

Record symptoms, temperature, weight, intake, bowel or urine changes, pain, activity, medicines, and treatment-specific effects.

Protect nutrition and mobility

Dietitian-led nutrition, safe activity, fall prevention, swallowing support, and rehabilitation can preserve treatment tolerance.

Manage survivorship effects

Heart, lung, hormone, nerve, fertility, bone, cognitive, emotional, and second-cancer risks vary by therapy and need planned review.

Coordinate surveillance

Use the cancer-specific schedule for examination, imaging, laboratory work, symptom review, and recurrence assessment; more testing is not always better.

Keep palliative care available

Symptom, communication, family, and quality-of-life support can be used alongside disease-directed treatment at any stage.

Risks and edge cases

Events that can change eligibility, city, stay, or cost

Incorrect or incomplete diagnosis

Small samples, mixed tumors, interpretation differences, or missing biomarkers can lead to the wrong treatment.

Review tissue before irreversible care.

Treatment toxicity

Infection, marrow suppression, organ injury, thrombosis, bleeding, neuropathy, wound trouble, or radiation effects may interrupt treatment.

Know the emergency route.

Unexpected progression

Cancer may grow despite treatment or reveal new sites, requiring a revised intent and sequence.

Build decision checkpoints.

Drug access or duration uncertainty

Imported medicines, authorization, body-size dosing, wastage, response, and indefinite maintenance can change costs.

Never assume one cycle equals a course.

Rare or inherited cancer

Unusual pathology, young age, family history, or multiple cancers may require expert pathology and genetic counseling.

Testing can affect relatives.

Care across countries

Different drug brands, radiation records, pathology access, emergency thresholds, and follow-up responsibilities can fragment care.

Use a named coordinating clinician.

Reports for review

Prepare a useful case file before comparing hospitals

Send source evidence, not summaries alone: pathology material, DICOM imaging, complete treatment names and doses, radiation and operation records, response studies, toxicity, and current clinical status allow a meaningful Delhi review.

Upload medical reports

Diagnosis and stage file

These records establish what the disease is and where it is.

Pathology

Report, slides or blocks availability, biopsy method, immunohistochemistry, cytogenetics, molecular results, and outside reviews.

Imaging

DICOM CT, MRI, PET, ultrasound, bone, nuclear, or endoscopic studies with reports and prior comparisons.

Clinical stage

Examination, operative findings, stage used by the treating team, symptoms, performance, weight, and current disease sites.

Laboratory and biomarkers

CBC, organ function, tumor markers when relevant, viral screening, receptors, mutations, and germline results if performed.

Treatment and safety file

These records prevent repetition and support the next decision.

Prior treatment

Operation notes, margins, drug generic names, doses, dates, cycles, radiation plan and dose, transplant or intervention records.

Response and toxicity

Serial imaging, marker trends, admissions, infections, transfusions, dose reductions, allergies, neuropathy, and organ injury.

Current medicines and health

Cancer and supportive drugs, anticoagulants, steroids, pain medicines, comorbidities, fertility concerns, and functional limitations.

Travel and continuity

Passport, visa, attendant, dates, mobility or isolation needs, home oncologist, emergency hospital, and local access to tests or infusions.

International patient notes

Documents, payments, language, and attendant planning

Use official visa information

Apply through the Government of India portal with correspondence that accurately describes consultation and provisional treatment.

Check fitness before travel

Low counts, infection, oxygen need, clot, bleeding, obstruction, neurologic symptoms, and recent intensive treatment can make flying unsafe.

Plan medicine supply

Confirm generic drug, dose, schedule, storage, import or export rules, and home availability before starting a long course.

Name the handover clinician

Decide who will receive pathology, imaging, doses, toxicity, response criteria, surveillance, and emergency responsibility after return.

Procedure-specific planning

Pathology, stage, tumor board, and complete-course pricing

The strongest cancer plan turns a broad diagnosis into a documented sequence. It explains what evidence supports treatment, how benefit will be measured, which phase comes next, and how the budget changes if response or tolerance differs.

Pathology certainty

State cancer type, grade, immunophenotype, molecular findings, specimen adequacy, and unresolved questions.

A report review may change treatment.

Stage and intent

Document disease extent and whether the goal is cure, long control, symptom relief, or diagnosis.

Intent should be discussed openly.

Tumor-board sequence

List each modality, order, timing dependencies, and the clinician responsible for transitions.

Avoid disconnected opinions.

Course-level cost

Price drug and dose per cycle, planned cycles, radiation technique and fractions, surgery, tests, supportive medicines, and admissions.

A unit price is not a total.

Response checkpoint

Define when and how treatment benefit, toxicity, resectability, or progression will be assessed.

The next phase remains conditional.

Portable treatment record

Preserve pathology material, DICOM, operation note, radiation DICOM or summary, and exact systemic doses.

Future teams need source data.

Consultation checklist

Questions to ask the hospital and treating team

What proves the diagnosis?

Ask whether tissue is adequate and which pathology or biomarker uncertainty could change treatment.

What is the stage and intent?

Request a plain-language description of disease extent, goal, expected benefit, and uncertainty.

Who reviewed the case?

Identify the organ-specific surgeon, medical oncologist, radiation oncologist, pathologist, radiologist, and supportive specialists.

What is the complete sequence?

List every planned phase, timing, response test, alternative, and responsibility for handoffs.

What is the total likely cost?

Request per-cycle and course drug arithmetic, complete radiation pricing, operation scope, tests, supportive care, and complication terms.

Can care continue at home?

Clarify which tests or treatments can transfer, medicine availability, emergency thresholds, records, and follow-up ownership.

Common questions

Questions about treatment in Delhi

How much does cancer treatment cost in Delhi?

Selected localized treatment may cost roughly INR 5,00,000 to 15,00,000. Multimodal care can reach INR 15,00,000 to 35,00,000, while targeted, immune, cellular, prolonged, recurrent, or complicated treatment may exceed INR 75,00,000. Only a diagnosis-specific plan can refine this.

Which is the best cancer hospital in Delhi?

There is no best hospital for every cancer. Match the exact subtype and stage to organ-specific surgery, medical and radiation oncology, pathology, imaging, ICU and supportive care, then compare access time, campus, records, estimate, and continuity.

Why is pathology review important?

Cancer subtype, grade, biomarkers, and sample quality can change surgery, radiation, drug choice, prognosis, and trial eligibility. Review is particularly useful for rare tumors, small biopsies, conflicting opinions, or treatment that depends on a molecular result.

Can cancer treatment be quoted as one package?

Usually not responsibly. A useful estimate names tests, operation, radiation technique and fractions, medicine and dose per cycle, number of planned cycles, supportive drugs, admissions, response checks, and exclusions.

Are chemotherapy and immunotherapy the same?

No. They work differently, apply to different diseases and biomarkers, have different dosing and side effects, and may be used alone or together. The team should name the exact medicine and explain why it fits.

How long should I stay in Delhi?

It depends on the pathway. Diagnostic review may take days, surgery commonly requires several weeks including recovery, and radiation or systemic therapy may involve repeated visits over weeks or months. The team should identify which phases can safely move home.

Is the AIIMS National Cancer Institute in central Delhi?

Patients should verify the location of every appointment. The NCI campus is at Jhajjar, while other AIIMS oncology services are associated with New Delhi. Consultation, treatment, imaging, and lodging plans should use the actual campus address.

What symptoms during cancer treatment are urgent?

Fever during chemotherapy, severe breathlessness, uncontrolled bleeding, new weakness or confusion, seizures, chest pain, persistent vomiting, dehydration, bowel obstruction symptoms, or uncontrolled pain requires urgent advice or emergency assessment.

Can I complete part of treatment in my home country?

Often, if the Delhi and home teams agree on generic medicine, dose, schedule, laboratory thresholds, radiation or surgical records, response criteria, emergency plan, and responsibility. Availability and quality of the required service must be confirmed first.

What should I send for a Delhi cancer opinion?

Send pathology report and material details, complete DICOM imaging, stage, operation and radiation records, exact medicines and doses, response scans, laboratory trends, toxicity and admissions, current symptoms, health conditions, and the existing treatment recommendation.

Review and sources

How this city guide was prepared

This guide combines official Delhi oncology-service evidence, authoritative cancer diagnosis and staging references, and Virello Health private-care benchmarks. It separates localized, multimodal, and prolonged advanced pathways because no single cancer tariff is clinically meaningful. A patient-specific plan requires pathology, staging, organ function, treatment intent, named modalities, response checkpoints, and written phase estimates.

This page does not diagnose cancer, assign stage, recommend a treatment, predict response, or guarantee cost or outcome. Cancer emergencies require immediate local assessment. Every plan must be individualized by appropriately qualified organ-specific oncology, pathology, radiology, supportive-care, and hospital teams.

Surgical oncology (opens in a new tab)

AIIMS New Delhi · Accessed 2026-07-20

Supports: Official Delhi surgical-oncology, multidisciplinary, ICU, and NCI context.

Radiation oncology (opens in a new tab)

AIIMS New Delhi · Accessed 2026-07-20

Supports: Official radiation-oncology service and treatment context.

Cancer diagnosis and staging (opens in a new tab)

National Cancer Institute · Accessed 2026-07-20

Supports: Biopsy, pathology, imaging, biomarkers, and staging principles.

Cancer fact sheet (opens in a new tab)

World Health Organization · Accessed 2026-07-20

Supports: Cancer burden, early diagnosis, treatment, and palliative-care context.

National Cancer Registry Programme (opens in a new tab)

ICMR National Centre for Disease Informatics and Research · Accessed 2026-07-20

Supports: Indian population-based cancer context and disease patterns.

NABH accredited organizations (opens in a new tab)

National Accreditation Board for Hospitals and Healthcare Providers · Accessed 2026-07-20

Supports: Independent route to verify Indian hospital accreditation.

Indian medical visa service (opens in a new tab)

Government of India · Accessed 2026-07-20

Supports: Official visa route for international patients and attendants.

RBI reference-rate release (opens in a new tab)

Reserve Bank of India · Accessed 2026-07-20

Supports: INR 96.3665 per USD conversion dated 17 July 2026.

Related planning